No profile data available.
Seer, Inc. (SEER) is a healthcare company in the biological analysis equipment industry, based in Redwood City, United States, with about 134 full-time employees.
It reported revenue of $16.12 million for fiscal year 2025, up 15.6% from fiscal year 2024, and net income of -$73.60 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $2.71 million, down 34.7% from a year before. Its market capitalization was $108.17 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a life sciences company, develops and commercializes products to decode the biology of the proteome.
Seer reported $16.12 million in revenue for fiscal year 2025, up 15.6% from $13.95 million in fiscal year 2024. In Q1 2026 revenue was $2.71 million.
$108.17 million as of December 4, 2025.
Listed companies of a similar size in the same industry (biological analysis equipment) include Alpha Teknova, Inc. (TKNO), Quanterix Corporation (QTRX), MaxCyte, Inc. (MXCT), INmune Bio, Inc. (INMB).